Review
Accepted on 18 Nov 2024
The role of circulating tumour DNA in melanomas of the uveal tract
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1509968
Type at least 3 characters
6,666 articles
Articles
Review
Accepted on 18 Nov 2024
Microbiome in urologic neoplasms: focusing on tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1507355
Original Research
Accepted on 18 Nov 2024
Integrating Necroptosis into Pan-Cancer Immunotherapy: A New Era of Personalized Treatment Author and affiliations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1510079
Original Research
Accepted on 18 Nov 2024
AMBRA1 drives gastric cancer progression through regulation of tumor plasticity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1494364
Review
Accepted on 18 Nov 2024
Harnessing m1A Modification: A New Frontier in Cancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1517604
Original Research
Accepted on 18 Nov 2024
Alternative Splicing Regulation by Tumor Suppressing Subtransferable Candidate 4: A Pathway to Tumor Suppression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474527
Original Research
Accepted on 18 Nov 2024
Pan-cancer single cell and spatial transcriptomics analysis deciphers the molecular landscapes of senescence related cancer-associated fibroblasts and reveals its predictive value in neuroblastoma via integrated multi-omics analysis and machine learning
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1506256
Original Research
Accepted on 18 Nov 2024
Potency of NK cells-derived extracellular vesicles as a natural antitumor tool in the biotherapy of B cell lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1503857
Case Report
Accepted on 18 Nov 2024
Case Report: Therapeutic Response of Front-line Cadonilimab plus Chemotherapy on Patient with Advanced Lung Adenocarcinoma Harboring STK11 Genetic Aberration
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1485358
Review
Accepted on 18 Nov 2024
Advances in Biomarkers for Immunotherapy in Small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490590
Original Research
Accepted on 18 Nov 2024
Integrating Omics data and Machine Learning Techniques for Precision Detection of Oral Squamous Cell Carcinoma: Evaluating Single Biomarkers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493377
- 112 views
Original Research
Accepted on 18 Nov 2024
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1485461
Original Research
Accepted on 18 Nov 2024
Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425687
Mini Review
Accepted on 18 Nov 2024
Radioimmunotherapy: A Game-Changer for Advanced Non-Small Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1522508
Original Research
Accepted on 18 Nov 2024
The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1488042
Original Research
Accepted on 18 Nov 2024
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1507371